Advanced Medical Optics, Inc. (AMO) (NYSE:EYE), today announced that
Chairman and CEO Jim Mazzo will present a corporate overview of the
company at the Credit Suisse Healthcare Conference in Phoenix on
Wednesday, November 12 at 1:30pm EST.
To access an audio webcast of the presentation, please visit the
investor section of AMO’s Website at www.amo-inc.com.
About Advanced Medical Optics (AMO)
AMO is focused on providing the full range of advanced refractive
technologies and support to help eye care professionals deliver optimal
vision and lifestyle experiences to patients of all ages. Products in
the cataract line include monofocal intraocular lenses (IOLs),
phacoemulsification systems, viscoelastics, and related products used in
ocular surgery. AMO owns or has the rights to such product brands as
Tecnis®, Clariflex®
and Sensar® IOLs; Sovereign®,
Sovereign® Compact and WhiteStar Signature™
phacoemulsification systems with WhiteStar®
technology; Healon® viscoelastics and the
Baerveldt® glaucoma shunt. Products in the
refractive line include wavefront diagnostic devices, femtosecond lasers
and associated patient interface devices; excimer laser vision
correction systems and treatment cards, and refractive implants. AMO
brands in the refractive business include iDesign™,
iFS™, Star S4 IR®,
WaveScan Wavefront®, Advanced CustomVue™,
IntraLase®, IntraLasik®
and ReZoom®, Tecnis®
Multifocal and Verisyse® IOLs. Products in
the eye care line include disinfecting solutions, enzymatic cleaners,
lens rewetting drops and artificial tears. Among the eye care product
brands the company possesses are COMPLETE®,
COMPLETE® Blink-N-Clean®,
Consept®F, Consept®
1 Step, Oxysept® 1 Step, UltraCare®,
Ultrazyme®, Total Care™
and blink® branded products. AMO is based in
Santa Ana, California, and employs approximately 3,900 worldwide. The
company has operations in 27 countries and markets products in
approximately 60 countries. For more information, visit the company's
Website at www.amo-inc.com.